170 related articles for article (PubMed ID: 15833880)
21. Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana.
Bhardwaj N; Rosas LE; Lafuse WP; Satoskar AR
Int J Parasitol; 2005 Jan; 35(1):75-82. PubMed ID: 15619518
[TBL] [Abstract][Full Text] [Related]
22. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
23. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
Walters DK; Jelinek DF
Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
[TBL] [Abstract][Full Text] [Related]
24. Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cells.
Kurdi M; Booz GW
J Interferon Cytokine Res; 2007 Jan; 27(1):23-31. PubMed ID: 17266440
[TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three.
Flati V; Haque SJ; Williams BR
EMBO J; 1996 Apr; 15(7):1566-71. PubMed ID: 8612580
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
Nandan D; Reiner NE
J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
[TBL] [Abstract][Full Text] [Related]
27. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
Müller M; Briscoe J; Laxton C; Guschin D; Ziemiecki A; Silvennoinen O; Harpur AG; Barbieri G; Witthuhn BA; Schindler C
Nature; 1993 Nov; 366(6451):129-35. PubMed ID: 8232552
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the IFN-gamma-signaling pathway in macrophages at different stages of maturation.
Lucas DM; Lokuta MA; McDowell MA; Doan JE; Paulnock DM
J Immunol; 1998 May; 160(9):4337-42. PubMed ID: 9574537
[TBL] [Abstract][Full Text] [Related]
29. Interaction of p59fyn with interferon-activated Jak kinases.
Uddin S; Sher DA; Alsayed Y; Pons S; Colamonici OR; Fish EN; White MF; Platanias LC
Biochem Biophys Res Commun; 1997 Jun; 235(1):83-8. PubMed ID: 9196040
[TBL] [Abstract][Full Text] [Related]
30. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
Wedel S; Hudak L; Seibel JM; Juengel E; Oppermann E; Haferkamp A; Blaheta RA
Prostate; 2011 May; 71(7):722-35. PubMed ID: 20954195
[TBL] [Abstract][Full Text] [Related]
31. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
Lee YJ; Benveniste EN
J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
[TBL] [Abstract][Full Text] [Related]
32. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
33. Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma.
Gollob JA; Sciambi CJ; Huang Z; Dressman HK
Cancer Res; 2005 Oct; 65(19):8869-77. PubMed ID: 16204058
[TBL] [Abstract][Full Text] [Related]
34. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures.
Dell'Albani P; Santangelo R; Torrisi L; Nicoletti VG; de Vellis J; Giuffrida Stella AM
J Neurosci Res; 2001 Sep; 65(5):417-24. PubMed ID: 11536325
[TBL] [Abstract][Full Text] [Related]
35. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
[TBL] [Abstract][Full Text] [Related]
36. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
Samanta A; Qian X; Greene MI
DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
38. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.
Wang X; Breeze A; Kulka M
Cancer Immunol Immunother; 2015 Feb; 64(2):249-58. PubMed ID: 25351720
[TBL] [Abstract][Full Text] [Related]
39. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation.
Sexl V; Kovacic B; Piekorz R; Moriggl R; Stoiber D; Hoffmeyer A; Liebminger R; Kudlacek O; Weisz E; Rothammer K; Ihle JN
Blood; 2003 Jun; 101(12):4937-43. PubMed ID: 12576323
[TBL] [Abstract][Full Text] [Related]
40. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.
Daza-Cajigal V; Albuquerque AS; Young DF; Ciancanelli MJ; Moulding D; Angulo I; Jeanne-Julien V; Rosain J; Minskaia E; Casanova JL; Boisson-Dupuis S; Bustamante J; Randall RE; McHugh TD; Thrasher AJ; Burns SO
Front Immunol; 2022; 13():888427. PubMed ID: 36159783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
